Patent application number | Description | Published |
20090105427 | Cleavable Block Copolymers, Functionalized Nanoporous Thin Films and Related Methods of Preparation - Cleavable, disulfide-coupled block copolymers as can be used in the preparation of nanoporous thin films, micellar configurations and related structures. | 04-23-2009 |
20090184047 | Functionalized nanopore membranes and related methods of use - Functionalized nanopore membranes, apparatus and related methods, as can be used for selective analyte detection and/or separation. | 07-23-2009 |
20110178190 | COMB POLYMERS FOR SUPRAMOLECULAR NANOCONFINEMENT - Polymers including pendent hydrophobic groups and pendent proton transfer groups are shown to form nanostructured films exhibiting greatly increased proton conductivity compared with films prepared from corresponding polymers lacking hydrophobic groups. The polymers can include repeating units each of which has both a hydrophobic group and a proton transfer group. Alternatively, the polymers can be the product of copolymerizing a first monomer with at least one hydrophobic group and a second monomer with at least one proton transfer group. The polymers are useful for the preparation of fuel cell proton exchange membranes. | 07-21-2011 |
20110200675 | DRUG DELIVERY VEHICLES, METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF - Drug delivery vehicles that release one or more drugs, e.g., an opioid antagonist and/or an opioid, in response to changes in the chemistry of body fluids, specifically in response to changes in the partial pressure of CO | 08-18-2011 |
20120183983 | Polymeric Reverse Micelles as Selective Extraction Agents and Related Methods of MALDI-MS Analysis - Methods for liquid-liquid extraction, as can be effected using polymeric reverse micelles, such methods as can be used in conjunction with various mass spectrometric techniques. | 07-19-2012 |
20130190409 | DRUG DELIVERY VEHICLES, METHODS OF MANUFACTURE, AND METHODS OF USE THEREOF - Drug delivery vehicles that release one or more drugs, e.g., an opioid antagonist and/or an opioid, in response to changes in the chemistry of body fluids, specifically in response to changes in the partial pressure of CO | 07-25-2013 |
20140112881 | CROSSLINKED POLYMER NANO-ASSEMBLIES AND USES THEREOF - The invention provides a novel system of nano-assemblies and related method for delivery of therapeutic, diagnostic or imaging agent to biological sites. The compositions and methods of the invention enable the syntheses of novel polymeric nano-assemblies (nanoparticles) under non-emulsion conditions with the incorporation of hydrophobic guest molecules. The versatilities and advantages of the polymer nanoparticles of the invention include: (i) the guest molecules (e.g., drug molecules) can be readily incorporated non-covalently within the nanoparticles; (ii) the surface of the nanoparticles are functionalizable; (iii) the non-covalently encapsulated guest molecule (payload) can be released in response to a biologically relevant stimulus at the target site; (iv) the payload is held by the polymeric nanoparticle before being internalized in cells and can be released within the cellular interiors; (v) encapsulating lipophilic small molecules within its crosslinked interiors and binding proteins on its surface through electrostatic interactions; (vi) facile synthetic methods for ligand functionalization that can be utilized to decorate nanogels with cell targeting ligands that facilitate receptor-dependent cellular uptake, and (vii) the payload release kinetics is tunable and controllable. | 04-24-2014 |
20140275417 | ORGANOBORONATE NANOPARTICLES AND METHODS OF USING THE SAME - In various embodiments, the present invention provides an organoboronate nanoparticle. The nanoparticle includes a polymer, which includes a repeating unit that includes at least one organoboronate functional group. Various embodiments provide compositions including the nanoparticles, surface functionalized nanoparticles, nanoparticles including an encapsulant, methods of making the nanoparticles, and methods of using the nanoparticles, such as methods of stimuli-responsive release of encapsulants. | 09-18-2014 |